Key Highlights
● Nasdaq-100 futures were sliding Thursday morning.
● The VIX climbed for the first time in five sessions.
● Eli Lilly was up about 2.8% to 3% premarket.
● Health care is an obvious candidate for shelter.
With Nasdaq-100 futures sliding and the VIX climbing for the first time in five sessions, investors looking for shelter on Thursday morning have an obvious candidate in health care: Eli Lilly (NYSE:LLY), the sector's heavyweight, was up about 2.8% to 3% premarket on a Chinese approval for its oral GLP-1 pill.
Consumer staples, the other traditional hiding place, offer a murkier picture. Whether either sector actually attracts defensive money at the open is an open question; the case below is based on how these groups have historically behaved, not on confirmed flows this morning.
Why investors may look for cover
The trigger is Nvidia (NASDAQ:NVDA). The chipmaker was down roughly 6% to 7% premarket after reports said its board was preparing to decide whether to oust CEO Jensen Huang. Those reports and related allegations have not been independently confirmed, and reports said no final decision had been announced. Nasdaq-100 futures were down about 0.63% and S&P 500 futures about 0.31% as of 5:26 a.m. ET, while Dow futures edged up 0.09%.
The VIX, Wall Street's fear gauge, was up about 4.7% to 4.9% near 18.3 premarket, after falling to 17.49 on Wednesday. A Cboe SKEW reading of 149.09, suggests Demand for protection against sharp drops remains elevated.
Health care and staples typically hold up better in selloffs because demand for medicines, food and household goods tends to be steady regardless of the economic cycle. They also carry little direct exposure to the AI hardware story that is driving Thursday's volatility.
Health care has a catalyst; staples have question marks
Lilly's move is company-specific: China's National Medical Products Administration approved orforglipron, reported under the Brand name "Muyouda," which coverage framed as an edge over Novo Nordisk (NYSE:NVO) in China. Because Lilly is a large weight in the S&P 500 health care sector, its gain alone can support the group.
Staples are less clear-cut. Clorox (NYSE:CLX) fell about 3.6% on Wednesday after a seven-session win streak in which it gained more than 21%, and Brown-Forman (NYSE:BF.B) dropped roughly 3.4%. Unilever fell 1.04% despite a Deutsche Bank upgrade to Buy. Grocery Outlet (NASDAQ:GO) slid 6.42% after reporting third-quarter net sales growth of just 0.9% and trimming the top of its adjusted EBITDA guidance. Those moves suggest investors are being selective even within defensive sectors.
What to Watch Next on Healthcare and Staples
The biggest problem for defensive stocks is interest rates. Health care and staples are often valued partly for their dividends, and the 10-year Treasury Yield was near 5% Thursday morning, making bonds a more competitive alternative. Markets priced roughly 85% to 90% odds of a quarter-point Fed rate hike in December. Higher yields can limit how far defensive sectors rally even when tech falls.
Consumer softness is another concern for staples. The NRF/CNBC retail monitor showed October retail sales rose only 0.2% from September, the slowest since November 2025, and NRF CEO Matthew Shay said "households are managing budgets carefully." That can pressure volumes for branded goods as shoppers trade down. A strong dollar near a 19-month high is a further headwind for multinational staples companies with large overseas sales.
Finally, a rotation may not materialize at all. Wednesday's market featured broad gains in energy and industrials, and some money may flow there rather than to defensives if the tech selloff stays contained.
At the open, compare health care and staples sector performance against technology. Weekly jobless claims at 8:30 a.m. ET and the 30-year Treasury auction at 1 p.m. will shape yields, the key variable for defensive valuations. Walmart (NASDAQ:WMT) and Target (NYSE:TGT) report next week.






Please wait processing your request...